Accessibility Menu
Eom Pharmaceuticals logo

Eom Pharmaceuticals

(OTC) IMUC

Current Price$0.20
Market Cap$25.30M
Since IPO (2021)-61%
5 Year-69%
1 Year+181%
1 Month+60%

Eom Pharmaceuticals Financials at a Glance

Market Cap

$25.30M

Revenue (TTM)

$0.00

Net Income (TTM)

-$2.65M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-0.02 (Low)

Price

$0.20

Volume

404

Open

$0.20

Previous Close

$0.20

Daily Range

$0.20 - $0.20

52-Week Range

$0.04 - $0.34

Estimated Earnings Date

N/A

IMUC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Eom Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

CEO

Irach B. Taraporewala, PhD

Website

www.eompharma.com

Headquarters

Montvale, NJ 07645, US

IMUC Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

127.66%

Return on Capital

N/A

Return on Assets

-1933.07%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$25.30M

Shares Outstanding

126.50M

Volume

404

Avg. Volume

7.44K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$2.89M

EBITDA

-$2.29M

Operating Cash Flow

-$689.34K

Capital Expenditure

$0.00

Free Cash Flow

-$689.34K

Cash & ST Invst.

$613.24K

Total Debt

$3.47M

Eom Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2022YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$25.30M

N/A

Market Cap/Employee

$8.43M

N/A

Employees

3

N/A

Net Income

-$464.53K

-15671.9%

EBITDA

-$315.40K

N/A

Quarterly Fundamentals

Name
Q4 2022YOY CHG

Total Cash

$613.24K

+4897.5%

Total Debt

$3.47M

+188.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$619.94K

-48.4%

Short Term Debt

$2.85M

N/A

Return on Assets

-19.33%

N/A

Return on Invested Capital

1.70%

N/A

Free Cash Flow

-$687.93K

N/A

Operating Cash Flow

-$687.93K

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DVHGFDevonian Health Group Inc.
$7.00+0.00%
LVCLFAlgorae Pharmaceuticals Limited
$0.01+0.00%
NYMXFNymox Pharmaceutical Corporation
$0.12+0.00%
PRVCFPreveCeutical Medical Inc.
$0.01-18.49%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$194.84-0.01%
ABTCAmerican Bitcoin
$8.43-0.10%
AAPLApple
$308.74+0.05%
TSLATesla
$394.04-0.07%

Questions About IMUC

What is the current price of Eom Pharmaceuticals?

Eom Pharmaceuticals is trading at $0.20 per share.

What is the 52-week range for Eom Pharmaceuticals?

Over the past 52 weeks, Eom Pharmaceuticals has traded between $0.04 and $0.34.

How much debt does Eom Pharmaceuticals have?

As of the most recent reporting period, Eom Pharmaceuticals reported total debt of $1.76M.

How much cash does Eom Pharmaceuticals have on hand?

Eom Pharmaceuticals reported $29.76K in cash and cash equivalents in its most recent financial results.

What is Eom Pharmaceuticals’s dividend yield?

Eom Pharmaceuticals does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services